GlaxoSmithKline Consumer Healthcare, which declared its financial results for the 15-month period ended March 31, 2014, posted net sales of ₹4,683 crore. The company’s net profit stood at ₹675 crore for this period.
In a BSE filing, the company said: “The accounting year of the company has been changed from January-December to April-March. Accordingly, the current year’s financial statements are for a period of 15 months, from January 1, 2013, to March 31, 2014. These figures are not comparable with those of the previous year ended December 31, 2012.”
For the quarter ended March 31, 2014, the company posted net profit of ₹171.7 crore, up from ₹156.40 crore for the corresponding quarter last year.
Total income for the quarter stood at ₹1,167.82 crore, up from ₹1,007.8 crore for the quarter ended March 31, 2013. The board recommended a dividend at ₹45 a share (equity share of ₹10 each) for the 15-month period.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.